Dykstra goes to bat for Lincare stock
CLEARWATER, Fla. - Former big league baseball player turned stock picker Lenny Dykstra thinks Lincare could be a grand slam for long-term investors. In a recent online posting, Dykstra called the company the front-runner in treating respiratory diseases, the fourth leading cause of death in the United States. He pointed out that Lincare currently comprises $1.45 billion of the $5 billion home respiratory market. The future looks bright for the provider due to the aging baby-boomer population and the increasing popularity of in-home treatment, Dykstra wrote.